Table 3.

Univariate log-rank analysis for clinicopathologic features and AZGP1 expression

Parameter	Case	DSS		LRFS		MeFS
		No of events	P-value	No of events	P-value	No of events	P-value
Age (years)			0.128		0.052		0.953
≤60	125	100		31		53
>60	90	75		22		40
Gender			0.816		0.790		0.119
Male	123	105		29		53
Female	92	70		24		40
Location			0.364		0.582		0.573
Upper	43	35		12		21
Middle	108	83		23		44
Lower	64	57		18		28
Differentiation			0.002*		0.080		0.244
Well	31	21		5		9
Moderate	135	111		35		60
Poor	49	43		13		24
T category			0.000*		0.001*		0.005*
T1	14	9		2		1
T2	43	31		5		7
T3	78	63		14		35
T4	80	72		32		50
N category			0.000*		0.000*		0.000*
N0	116	88		19		38
N1	99	87		34		55
AZGP1 expression			0.000*		0.026*		0.018*
Downregulation	118	101		33		55
Normal expression	97	74		20		38
General classification			0.870		0.140		0.743
Medullary type	117	102		25		56
Ulcerative type	54	41		15		20
Sclerotic type	21	17		6		7
Mushroom type	23	15		7		10

Notes:

^*Statistically significant. TNM staging is based on AJCC Guidelines.¹⁰

Abbreviations: DSS, disease-special survival; LRFS, local recurrence-free survival; MeFS, metastasis-free survival.